Skip to main content
WELLELL logo

WELLELL — Investor Relations & Filings

Ticker · 4106 ISIN · TW0004106000 TW Manufacturing
Open in API
Filings indexed 1,632 across all filing types
Latest filing 2024-11-29 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 4106

About WELLELL

https://tw.wellell.com/zh-tw

Wellell, formerly known as APEX Medical, is a global developer and manufacturer of medical solutions specializing in pressure relief and respiratory therapy. Established in 1990, the company focuses on improving the quality of life for patients and caregivers through advanced clinical equipment. Its core product portfolio includes medical air mattress systems for pressure injury prevention, continuous positive airway pressure (CPAP) devices for obstructive sleep apnea, and compression therapy systems for venous thromboembolism (VTE) intervention. Wellell integrates digital health technologies to create a Patient Recovery Care (PRC) ecosystem, enhancing treatment efficiency in both acute and post-acute care settings. With over 35 years of expertise, the company provides evidence-based medical devices and digital health services to support inpatient and outpatient recovery globally.

Recent filings

Filing Released Lang Actions
113年11月法人說明會簡報 — 410620241129E001.pdf
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial statements including a consolidated income statement, balance sheet (assets, liabilities, and owners' equity) for the third quarter of 2024 (3Q24), with comparative figures from 3Q23. It also includes operational updates and market expansion information. The presence of comprehensive financial data for a quarterly period, including income, expenses, assets, liabilities, and equity, indicates this is a substantive financial report for a period shorter than a full fiscal year. The document length is over 7,000 characters, and it is not merely an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-11-29 Chinese
113年11月法人說明會簡報 — 410620241129M001.pdf
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data for the first three quarters of 2024, including consolidated income statements, balance sheets (assets, liabilities, and equity), and segment revenue breakdowns. It also includes operational updates and participation in international medical exhibitions. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (2024 Q1-Q3) indicates this is an Interim / Quarterly Report. The document length is over 5,000 characters and contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-11-29 Chinese
113年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor conference or analyst meeting, including date, time, location, summary of the meeting content, and links to presentation materials and video recordings. The key phrase '法人說明會' translates to 'investor conference' or 'analyst meeting presentation.' This matches the definition of an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. The document is not a full report, audit, or earnings release, but rather materials related to an investor presentation event.
2024-11-29 Chinese
113年第3季海外子公司投資
Regulatory Filings Classification · 90% confidence The document contains detailed financial data about investments in overseas subsidiaries, including investment amounts, shareholding percentages, and recognized investment gains or losses for the current period and prior year-end. The data is presented in a tabular format with notes explaining accounting treatments, consistent with equity method investment disclosures. The document length is 2217 characters, which is relatively short and does not appear to be a full annual or interim report. There is no indication that this is an announcement or a certification. The content is financial and investment-related but does not match the typical structure of an Annual Report (10-K) or Interim Report (IR). It is more consistent with a Regulatory Filing (RNS) as a detailed disclosure of investment information required by securities regulators, especially given the presence of notes referencing accounting standards and the format typical of regulatory filings in Taiwan (公開資訊觀測站). Therefore, the best classification is Regulatory Filings (RNS).
2024-11-14 Chinese
113年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning the company's investments in mainland China. It includes specific financial figures such as capital amounts, investment methods, cumulative investment amounts, shareholding percentages, and investment gains or losses. The document also contains explanatory notes about the investment methods and accounting bases for recognizing investment gains or losses. The content is regulatory in nature, providing compliance information about overseas investments as required by Taiwanese authorities (e.g., Economic Ministry Investment Commission). The document length is short (1601 characters), and it does not present a full financial report or comprehensive financial statements. Instead, it is a regulatory disclosure of investment information. This type of document fits best under Regulatory Filings (RNS), as it is a compliance disclosure that does not constitute a full annual or interim report, audit report, or other specific report types.
2024-11-14 Chinese
113年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for the first three quarters of the fiscal year 2024 (民國113年前3季) and the same period in the previous year. It includes line items such as common stock, capital surplus, legal reserve, special reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, unrealized gains/losses on financial assets, treasury stock, and total equity attributable to the parent company and non-controlling interests. The presence of actual financial figures and comprehensive equity changes indicates this is a substantive financial report for an interim period rather than a brief announcement or certification. The document length is 3594 characters, which is relatively short but contains detailed financial tables, so it is not merely an announcement. The content matches the characteristics of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and provides substantive financial data and analysis. Therefore, the correct classification is IR (Interim / Quarterly Report). 9M 2024
2024-11-14 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.